TB/Micobactérias Não Tuberculosas
Revisão sistemática | Terapia de observação por vídeo vs. terapia de observação direta em pacientes com tuberculose.
10 Fev, 2022 | 12:56hVideo-Observed Therapy Versus Directly Observed Therapy in Patients With Tuberculosis – American Journal of Preventive Medicine (link para o resumo – $ para o texto completo)
Conteúdo relacionado: RCT: Electronic directly observed therapy is noninferior to in-person observed therapy for ensuring adherence to tuberculosis treatment.
Comentário no Twitter
Our latest publication on @AmJPrevMed : Video-Observed Therapy Versus Directly Observed Therapy in Patients With Tuberculosis. Implementation of VOT improved medication adherence and bacteriological resolution compared with that of DOT in TB patients.https://t.co/xcWzrxLbHB? pic.twitter.com/4ldYJ2umd7
— Bang Truong (@bangphd_epi) December 13, 2021
Estudo randomizado por cluster | Uma estratégia diagnóstica multicomponente (teste molecular para tuberculose, reestruturação dos fluxos clínicos e controle mensal de métricas de qualidade) melhorou sobremaneira as taxas de diagnóstico confirmado de tuberculose em 14 dias após a apresentação.
8 Fev, 2022 | 14:43hMulticomponent Strategy with Decentralized Molecular Testing for Tuberculosis – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentário no Twitter
A cluster-randomized trial in 20 Ugandan health centers compared a multicomponent TB strategy with routine care. The intervention led to greater numbers of patients being tested for, receiving a diagnosis of, and being treated for confirmed TB. https://t.co/PcJDC1I0CY pic.twitter.com/AT99QVOn2S
— NEJM (@NEJM) December 28, 2021
Estudo randomizado | Terapia de observação eletrônica direta é não inferior à terapia de observação pessoal para garantir a adesão ao tratamento da tuberculose.
28 Jan, 2022 | 15:30h
Comentário no Twitter
In this 2-year study, data showed that electronic directly observed therapy (eDOT) was as effective as traditional in-person DOT for ensuring high adherence to treatment of tuberculosis disease. @CDC_TB @nycHealthy @ColumbiaMed https://t.co/yTrU1JRuwn pic.twitter.com/QXthE4d266
— JAMA Network Open (@JAMANetworkOpen) January 20, 2022
Efeitos devastadores da Covid-19 sobre o cuidado da tuberculose – Um caminho de recuperação.
12 Jan, 2022 | 13:08h
Comentário no Twitter
In @NEJM today, @TerezaKasaeva @doctorsoumya and I write about
Covid-19’s devastating impact on tuberculosis care & offer suggestions for recoveryhttps://t.co/buOEOPVWwM pic.twitter.com/BfOK3X3MuU
— Madhu Pai, MD, PhD (@paimadhu) January 5, 2022
Relatório Clínico AAP | Tuberculose em crianças e adolescentes.
2 Dez, 2021 | 11:26hTuberculosis Infection in Children and Adolescents: Testing and Treatment – Pediatrics
Progresso global da tuberculose foi revertido pela pandemia de COVID-19.
19 Nov, 2021 | 13:14hGlobal tuberculosis progress reversed by COVID-19 pandemic – The Lancet Respiratory Diseases
Conteúdos relacionados:
How COVID is derailing the fight against HIV, TB and malaria.
How COVID hurt the fight against other dangerous diseases
World TB Day | Report: COVID-19 Eliminates Twelve Years of Progress Against Tuberculosis
Tuberculosis and Covid-19: Fighting a deadly syndemic
Comentário no Twitter
NEWS—Global #tuberculosis progress reversed by #COVID19 pandemic
"Due to the delayed effects from #COVID19, #tuberculosis deaths are projected to rise again in 2022 while the world readjusts to a new normality and services resume."
Read more here: https://t.co/tWVXswZsvs
— The Lancet Respiratory Medicine (@LancetRespirMed) November 3, 2021
Relatório OMS | Mortes por tuberculose aumentaram pela primeira vez em mais de uma década, em virtude da pandemia de COVID-19.
15 Out, 2021 | 16:38hRelatório: Global tuberculosis report 2021
Comentário: Tuberculosis deaths rise for 1st time in years, due to COVID – Associated Press
Comentário no Twitter (fio – clique para saber mais)
🆕 WHO's Global TB Report reveals deaths from #tuberculosis rise for the first time in more than a decade due to the #COVID19 pandemic.
1.5 million people died in 2020 & the number will continue to rise unless urgent action is taken 👉https://t.co/RFmWYIelhq #EndTB pic.twitter.com/33G7sI8K2J
— World Health Organization (WHO) (@WHO) October 14, 2021
Revisão sistemática | Pretomanida para tuberculose.
8 Out, 2021 | 10:59hPretomanid for tuberculosis: a systematic review – Clinical Microbiology and Infection
Conteúdos relacionados:
Summary | WHO recommendations on the treatment of drug-resistant tuberculosis, 2020 update.
WHO announces updated definitions of extensively drug-resistant tuberculosis
Como a COVID está atrapalhando a luta contra HIV, tuberculose e malária.
17 Set, 2021 | 12:01hHow COVID is derailing the fight against HIV, TB and malaria – Nature
Conteúdos relacionados:
How COVID hurt the fight against other dangerous diseases
World TB Day | Report: COVID-19 Eliminates Twelve Years of Progress Against Tuberculosis
Impacto econômico da mortalidade por tuberculose em 120 países e o custo de não se atingir os Objetivos de Desenvolvimento Sustentável relacionados a tuberculose: uma análise de renda total.
12 Set, 2021 | 21:42hComentário convidado: The incalculable costs of tuberculosis
Comentários no Twitter
A strong eeconomic case for ending TB – trillions of dollars in savings. Cost of not acting now is going to be too expensive! @StopTB https://t.co/ffLVTeqOkj
— Suvanand Sahu (@SahuSuvanand) September 5, 2021
Failure to achieve the SDG tuberculosis mortality target by 2030 will lead to profound economic and health losses:
$3·0 trillion will be lost if the target is not met until 2045!!
Sachil Silva, Nim Pathy, @mikereidmd @DrEricGoosby @RifatAtun https://t.co/ipm5vj62IQ @LancetGH pic.twitter.com/fPHDW5eJWE
— Madhu Pai, MD, PhD (@paimadhu) September 3, 2021